Mendus AB: Mendus secures second shareholder loan from Van Herk Investments and reduces the number of outstanding convertible bonds with Negma Group

07.03.2023 - Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company has closed a second loan under the terms of the commitment from its largest shareholder Van Herk ...

Related Keywords

Mario Brkulj ,Erik Manting ,Corey Davis ,Lotta Ferm ,Lifesci Advisors ,Negma Group ,Valency Communications ,Chief Financial Officer ,Van Herk Investments ,Abuse Regulation ,Sci Advisors ,Mendus Ab ,